BeStock  
Stocks › Biotechnology › MGTX

MeiraGTx Holdings MGTX

US equityMarket cap rank #3321Biotechnology
$7.98 −$0.16 (-1.97%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $7.98 0.00%
Open$8.04
Prev close$8.14
Day range$7.81 – $8.23
Volume1.01M
Market cap$779.89M
P/E (TTM)9.2
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership86.7%+0.69 pts vs. prior quarter
Institutions holding212+20 vs. prior quarter
Insider trades (recent)28 buys / 21 sellsNet buying
Short interest6.91% of floatDays to cover 10.8 · as of 30 Oct 2026
Short-sale volume share28.3%5-day average of daily volume

Short-sale volume as % of daily volume

19%26%34%42%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$719.2K (6 inflow days, 14 outflow days).

Net flow by order size, last 20 sessions

−$598.0KSuper−$121.2KBig−$1.2MMid+$194.3KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 45.2% of shares outstanding.

Largest holders

  • Sanofi12.70%
  • Perceptive Advisors LLC11.23%
  • Rubric Capital Management LP9.47%
  • Johnson & Johnson Innovation - JJDC, Inc.6.91%
  • BlackRock4.87%
  • Adage Capital Management, L.P.4.58%
  • Opaleye Management Inc.3.70%
  • Millennium Management LLC3.09%

By investor type

  • Hedge Fund30.34%
  • VC/PE Fund20.37%
  • Mutual Fund20.07%
  • Public Company14.38%
  • Individual/Insider3.47%
  • Insurance Company0.80%
  • Private Company0.41%
  • Government Pension Fund0.33%

Reported short interest has risen from 3.89% to 6.91% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
First Trust Advisors L.P. Mutual Fund 2026/Q3 +914,002 0.9%
Mackenzie Financial Corporation Mutual Fund 2026/Q3 +707,885 0.7%
Renaissance Technologies Corp. Hedge Fund 2026/Q3 +415,700 0.4%
Assenagon Asset Management S.A. Mutual Fund 2026/Q3 +225,363 0.2%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +755,879 0.8%
Rubric Capital Management LP Hedge Fund 2026/Q3 +2,100,000 9.3%
BlackRock Mutual Fund 2026/Q3 +1,589,030 5.0%
Opaleye Management Inc. Hedge Fund 2026/Q3 +1,426,741 3.6%
Woodline Partners LP Hedge Fund 2026/Q3 +1,199,812 1.5%
Jacobs Levy Equity Management Inc Mutual Fund 2026/Q3 +1,001,433 1.0%
Heights Capital Management, Inc. VC/PE Fund 2026/Q3 +850,000 0.9%
State Street Global Advisors Mutual Fund 2026/Q3 +639,844 1.5%
Long Focus Capital Management LLC Hedge Fund 2026/Q3 +555,555 1.1%
Citadel Advisors LLC Hedge Fund 2026/Q3 +534,494 0.7%
Teachers Insurance and Annuity Association-College Retirement Equities Fund Mutual Fund 2026/Q3 +505,858 0.7%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
19 Oct 2026 Richard Giroux Chief Financial Officer Automatic Disposition -56,000 $9.95 942,682
5 Oct 2026 Stuart Naylor Chief Scientific Officer of Ophthalmology Automatic Disposition -27,659 $10.64 613,187
5 Oct 2026 Stuart Naylor Chief Development Officer Intent to Sell (Form 144) -27,659 $10.64 –
22 Sep 2026 Alan Sebulsky Independent Director Other Derivative Acquisition +100,000 – 100,000
22 Sep 2026 Apothecary Capital LLC Initial Statement of Beneficial +0 – 34,500
17 Aug 2026 Alexandria Forbes Chief Executive Officer Automatic Disposition -62,000 $13.86 1,325,695
20 Jul 2026 Richard Giroux Chief Financial Officer Automatic Disposition -56,000 $12.51 998,682
6 Jul 2026 Stuart Naylor Chief Scientific Officer of Ophthalmology Automatic Disposition -27,659 $14.90 640,846
24 Jun 2026 Alexandria Forbes Chief Executive Officer Other Derivative Acquisition +980,000 – 980,000
24 Jun 2026 Richard Giroux Chief Financial Officer Other Derivative Acquisition +980,000 – 980,000
24 Jun 2026 Stuart Naylor Chief Scientific Officer of Ophthalmology Other Derivative Acquisition +70,000 – 70,000
24 Jun 2026 Robert Zeldin Chief Medical Officer Other Derivative Acquisition +100,000 – 100,000
24 Jun 2026 Robert Wollin General Counsel Other Derivative Acquisition +100,000 – 100,000
10 Jun 2026 Jiuyun Yu Independent Director Other Derivative Acquisition +60,000 – 60,000
10 Jun 2026 Thomas Shenk Independent Director & Member of Scientific Advisory Board Other Derivative Acquisition +69,662 – 69,662
10 Jun 2026 Keith Harris Independent Chairperson Other Derivative Acquisition +106,441 – 106,441
10 Jun 2026 Perceptive Advisors LLC Other Derivative Acquisition +60,000 – 60,000
10 Jun 2026 Nicole Seligman Independent Director Other Derivative Acquisition +60,000 – 60,000
10 Jun 2026 Neil Mendoza Independent Director Other Derivative Acquisition +66,641 – 66,641
10 Jun 2026 Ellen Hukkelhoven Director Other Derivative Acquisition +60,000 – 60,000

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 6,641,078 6.9% 10.8
15 Oct 2026 6,438,544 6.7% 6.5
30 Sep 2026 5,996,760 6.2% 5.0
15 Sep 2026 4,011,818 4.2% 6.1
31 Aug 2026 3,723,321 3.9% 4.7
14 Aug 2026 3,738,795 3.9% 8.1

Discussion

No comments yet — be the first to weigh in on MGTX.

Sign in to join the discussion.

Scroll to Top